Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James C. Czirr currently holds 5,614,457 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James C. Czirr has been a net seller of GALT stock. They have purchased $29.4K and sold $9.6M worth of shares.
James C. Czirr's most recent insider trade was on Dec 16, 2025, when they sold 30,681 shares at $6.66 per share.
James C. Czirr serves as Executive at GALECTIN THERAPEUTICS INC (GALT). They have executed 145 insider transactions totaling $9.6M over their tenure at the company.
James C. Czirr holds the position of Executive at GALECTIN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James C. Czirr has shown a selling trading pattern, with $29.4K in total purchases and $9.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James C. Czirr was on Jan 11, 2019, when they sold $6.0M worth of GALT shares. This transaction involved 2,000,000 shares at $3.00 per share.
James C. Czirr currently owns 5,614,457 shares of GALECTIN THERAPEUTICS INC (GALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James C. Czirr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James C. Czirr has 145 Form 4 filings on record as an insider at GALECTIN THERAPEUTICS INC.
Set alerts for James C. Czirr and 40,000+ other insiders.